Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess Adverse Events, Tolerability and How Single and Ascending Oral Doses of Nacresertib Move Through the Body In Healthy Adult Participants
Sponsor: AbbVie
Summary
The objectives for this 2 Part study are to assess the safety, tolerability, and pharmacokinetics following single ascending oral doses of nacresertib in healthy adult participants (Part 1) and to assess the safety, tolerability, and pharmacokinetics following multiple ascending oral doses in healthy adult participants (Part 2).
Official title: A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Ascending Oral Doses of Nacresertib in Healthy Adult Subjects
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
93
Start Date
2025-04-18
Completion Date
2026-05-07
Last Updated
2026-06-04
Healthy Volunteers
Yes
Conditions
Interventions
nacresertib
Oral
Placebo
Oral
Locations (1)
Acpru /Id# 274374
Grayslake, Illinois, United States